🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Withdrawn
Location
Arlington Cancer Center - Arlington
Start Date
2007-07
Trial ID
NCT00547443
Treatments Being Tested
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2002-05
Trial ID
NCT00042835
The purpose of this study is to assess the efficacy and safety of Apatinib ...
Status
Unknown
Location
Cancer Hospital, ChineseAMS
Start Date
2018-11-01
Trial ID
NCT03735082
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of t...
Status
Unknown
Location
The Central Hospital of Wuhan
Start Date
2024-06-01
Trial ID
NCT06363708
Treatments Being Tested
Combination chemo/radiotherapy trials in advanced/recurrent endometrial can...
Status
Completed
Location
Montefiore Medical Center
Start Date
2001-12
Trial ID
NCT00231868
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2019-12-01
Trial ID
NCT04261465
Treatments Being Tested
This study is a Phase 3 global, multicenter, placebo-controlled double-blin...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2021-01-12
Trial ID
NCT04472429
Treatments Being Tested
In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Status
Suspended
Location
Stanford University
Start Date
2021-04-08
Trial ID
NCT04585477
Initially, the prospect of metformin as a neoplastic treatment was consider...
Status
Unknown
Location
Gynecologic Oncology Associates
Start Date
2014-01
Trial ID
NCT02437812
Treatments Being Tested